These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 20095128

  • 1. Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients.
    Piwowar A, Knapik-Kordecka M, Warwas M.
    Br J Biomed Sci; 2009; 66(4):194-9. PubMed ID: 20095128
    [Abstract] [Full Text] [Related]

  • 2. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M.
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [Abstract] [Full Text] [Related]

  • 3. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy.
    Cvetković T, Mitić B, Lazarević G, Vlahović P, Antić S, Stefanović V.
    J Diabetes Complications; 2009 Oct; 23(5):337-42. PubMed ID: 18358753
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients.
    Piwowar A, Knapik-Kordecka M, Warwas M.
    Clin Invest Med; 2010 Apr 01; 33(2):E109. PubMed ID: 20370990
    [Abstract] [Full Text] [Related]

  • 5. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
    Shiju TM, Mohan V, Balasubramanyam M, Viswanathan P.
    J Diabetes Complications; 2015 Apr 01; 29(3):400-6. PubMed ID: 25619588
    [Abstract] [Full Text] [Related]

  • 6. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST, Tseng ST.
    Clin Exp Nephrol; 2017 Apr 01; 21(2):283-292. PubMed ID: 27233502
    [Abstract] [Full Text] [Related]

  • 7. Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy.
    Conti G, Caccamo D, Siligato R, Gembillo G, Satta E, Pazzano D, Carucci N, Carella A, Campo GD, Salvo A, Santoro D.
    Medicina (Kaunas); 2019 Oct 07; 55(10):. PubMed ID: 31591338
    [Abstract] [Full Text] [Related]

  • 8. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P, Gao J, Pu C, Feng G, Wang L, Huang L, Zhang Y.
    Clin Chim Acta; 2017 Mar 07; 466():31-37. PubMed ID: 28073663
    [Abstract] [Full Text] [Related]

  • 9. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
    Fawzy MS, Abu AlSel BT.
    J Diabetes Res; 2018 Mar 07; 2018():8517929. PubMed ID: 29850609
    [Abstract] [Full Text] [Related]

  • 10. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes.
    Li Q, Gong W, Yang Z, Lu B, Yang Y, Zhao W, Hu R.
    Diabetes Res Clin Pract; 2013 Jun 07; 100(3):385-90. PubMed ID: 23602322
    [Abstract] [Full Text] [Related]

  • 11. Oxidative protein damage parameters in plasma in chronic experimental diabetes in rats.
    Kayali R, Telci A, Cakatay U, Karaca C, Akcay T, Sivas A, Altug T.
    Eur J Med Res; 2003 Jul 31; 8(7):307-12. PubMed ID: 12911868
    [Abstract] [Full Text] [Related]

  • 12. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y, Li YM, Zhang S, Zhao JY, Liu CY.
    J Int Med Res; 2016 Apr 31; 44(2):278-86. PubMed ID: 26857862
    [Abstract] [Full Text] [Related]

  • 13. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Qiao YC, Chen YL, Pan YH, Ling W, Tian F, Zhang XX, Zhao HL.
    Medicine (Baltimore); 2017 Apr 31; 96(15):e6583. PubMed ID: 28403088
    [Abstract] [Full Text] [Related]

  • 14. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Apr 31; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 15. Urotensin-II level and its association with oxidative stress in early diabetic nephropathy.
    Tabur S, Korkmaz H, Eren MA, Oğuz E, Sabuncu T, Aksoy N.
    J Diabetes Complications; 2015 Apr 31; 29(1):115-9. PubMed ID: 25179234
    [Abstract] [Full Text] [Related]

  • 16. Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes.
    Mohammedi K, Bellili-Muñoz N, Driss F, Roussel R, Seta N, Fumeron F, Hadjadj S, Marre M, Velho G.
    PLoS One; 2014 Apr 31; 9(5):e96916. PubMed ID: 24819633
    [Abstract] [Full Text] [Related]

  • 17. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A, Dumnicka P, Kuśnierz-Cabala B, Gala-Błądzińska A, Ceranowicz P, Kucharz J, Ząbek-Adamska A, Maziarz B, Drożdż R, Kuźniewski M.
    Mediators Inflamm; 2018 Apr 31; 2018():7659243. PubMed ID: 30158836
    [Abstract] [Full Text] [Related]

  • 18. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S, Hamide A, Senthilkumar GP, Mehalingam V.
    Diabetes Metab Syndr; 2018 Sep 31; 12(5):649-652. PubMed ID: 29673928
    [Abstract] [Full Text] [Related]

  • 19. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z, Xu Y, Liu X, Nie Y, Zhao Z.
    Nephrology (Carlton); 2017 Jan 31; 22(1):58-64. PubMed ID: 26733347
    [Abstract] [Full Text] [Related]

  • 20. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C, Wang Q, Lv C, Qin N, Lei S, Yuan Q, Wang G.
    Diabetes Res Clin Pract; 2014 Nov 31; 106(2):343-50. PubMed ID: 25263500
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.